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Abstract Defects of respiratory chain protein complexes and
the ATP synthase are becoming increasingly implicated in human
disease. Recently, mutations in the ATPase 6 gene have been
shown to cause several different neurological disorders. The
product of this gene is homologous to the a subunit of the ATP
synthase of Escherichia coli. Here, mutations equivalent to those
described in humans have been introduced into the a subunit of E.
coli by site-directed mutagenesis, and the effects of these
mutations on the ATPase activity, ATP synthesis and ability
of the enzyme to pump protons studied in detail. The effects of
the mutations varied considerably. The mutation L262P (9185
T-C equivalent) caused a 70% loss of ATP synthesis activity,
reduced DCCD sensitivity, and lowered proton pumping activity.
The L207P (8993 T-C equivalent) reduced ATP synthesis by
50%, affected DCCD sensitivity, while proton pumping was only
marginally affected when measured by the standard AMCA
quenching assay. The other mutations studied affected the
functioning of the ATP synthase much less. The results confirm
that modeling of these point mutations in the E. coli enzyme is a
useful approach to determining how alterations in the ATPase 6
gene affect enzyme function and, therefore, how a pathogenic
effect can be exerted.
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1. Introduction
An F1F0 type ATP synthase is found in the inner mitochon-
drial membrane, the inner membrane of bacteria, and the
thylakoid membrane of chloroplasts, where it functions to
convert the free energy of the proton motive force into the
chemical energy source ATP. This large enzyme complex is
composed of two major parts, the F1 part which contains the
catalytic sites for ATP hydrolysis and synthesis, and the F0
part which contains the proton channel. The simplest enzyme
form is that of bacteria, which is composed of only eight
di¡erent subunits. In contrast, the mitochondrial (mt) ATP
synthase contains 16 or 17 di¡erent subunits (reviewed in
[1^3]).
Two subunits of the mt ATP synthase, subunits 6 and 6AL,
are encoded on mtDNA [4]. Mutations in mtDNA, including
ones in the ATP synthase genes, have been implicated in sev-
eral human diseases [4]. The most common mutation of ATP-
ase 6, the T8993G mutation, has been found in several studies
[5^7] to cause variously NARP, Leigh’s syndrome and FSBN,
each a serious metabolic, mostly neurological disease of child-
hood. Other mutations of subunit 6 have been reported [8^14]
and implicated in the above diseases, as well as in LHON [15],
but the evidence that the speci¢c mutation described is re-
sponsible for the observed phenotype is not always easily
obtained. One issue is that many of these interesting muta-
tions are heteroplasmic; that is, they occur only in a percent-
age of the many copies of mtDNA per cell. The signi¢cance of
this heteroplasmy is related to the so-called threshold e¡ect of
mitochondrial diseases[4,16]. It is possible to deplete some
cells of components of oxidative phosphorylation without ob-
servable e¡ect on cellular functioning. For example, inhibition
of up to 70% of the cytochrome c oxidase activity of muscle
cells by inhibitors, or through a heteroplasmic mutation,
shows little or no e¡ect on the overall rate of oxidative phos-
phorylation [17]. Threshold levels of each enzyme are likely to
be di¡erent for di¡erent tissues, in di¡erent developmental
stages, and in age-related ways. Therefore, heteroplasmic mu-
tations of mtDNA with a partial reduction of enzyme assem-
bly or functioning may be deleterious in some, but not all cell
types.
Examination of genotype-phenotype relationships for mu-
tations of the ATPase 6 gene is additionally complicated by
the di⁄culty in measuring structural and functional parame-
ters of the ATP synthase in the limited amounts of tissue or in
cell lines derived from patients. Straightforward approaches to
measuring the amount of enzyme assembled are still not avail-
able, and measurements of ATP synthesis are di⁄cult and
rarely performed. One way that has been used to evaluate
the functional e¡ects of identi¢ed ATPase 6 mutants is to
make similar amino acid changes in the equivalent subunit
of the ATP synthase from Escherichia coli, subunit a [18].
By this approach, Hartzog and Cain [18] con¢rmed the path-
ogenicity of the T8993G mutation. They showed that this
change of a Leu to Arg a¡ected stability, blocked proton
translocation, and abolished ATP synthesis. Since this earlier
study, several new mutations of the human ATPase 6 gene
have been reported. Here, we have examined these new muta-
tions when generated in the E. coli enzyme.
2. Materials and methods
2.1. Construction of mutants in the uncB gene
A 2658 bp fragment of the unc operon containing the uncB, E, F, H
and part of uncA genes was isolated from pRA100 [19] using the
restriction enzymes HindIII and S¢I. The fragment was inserted
into the HindIII-SmaI sites of M13mp18 by ¢rst blunting the S¢I
end. Five mutations were introduced into the uncB gene by site-di-
rected mutagenesis [20] using the oligonucleotides shown in Table 1.
Site-directed mutagenesis was carried out using E. coli strain CJ236,
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and all subcloning was carried out in XL1 blue cells. The presence of
the mutations for 9176 T-C was con¢rmed by sequencing single-
stranded DNA from the M13mp18 plasmid using the following oli-
gonucleotide as a primer: CAC TGG GTG TAC GTA TCC TGA
TTC. The other mutations were shown to be present due to the
change in restriction patterns they conferred. The 8851 T-C mutation
resulted in the gain of a SnaBI site at position 4458 of the unc operon;
the 8993 T-C mutation produced the gain of an NciI site at position
4605; the 9101 T-C mutation, the loss of a Tsp45I site at 4680; and
the 9185 T-C mutation, the loss of a PvuI site at position 4769. The
mutated portions of the uncB gene were excised from M13mp18 using
DraIII (sites at positions 4403, 5895 and 10995). The 1582 bp frag-
ment containing the mutant and the additional 5610 bp fragment of
the unc operon were inserted back into the pRA100 plasmid. The
DraIII sites each consist of a di¡erent sequence and, therefore, ori-
entate themselves correctly on ligation. The presence of the 8851 T-C,
8993 T-C, 9101 T-C, and 9185 T-C mutations was checked using
restriction digests as for the M13mp18, and the resulting plasmids
were designated pIO 13, pIO 8, pIO 9 and pIO 10 respectively. Cor-
rect insertion of the 1582 bp fragment for the 9176 T-C (pIO 11)
mutation was done by inserting it into pIO 8 and looking for the
loss of the NciI site introduced at position 4605. Once constructed,
the plasmids were transformed into the AN888 strain where the F1F0
is expressed. AN1460 was used as a control strain. AN888 cells con-
taining each of the plasmids pIO 8^13 and AN1460 were grown in 2 l
of LB broth overnight. The cells were then harvested and an inner
membrane fraction isolated as described in Aggeler et al. [21].
2.2. ATPase assays and DCCD sensitivity
ATPase activities of the mutant inner membranes were measured
using the method of Lo«tscher et al. [22] and the DCCD sensitivity of
these activities was assessed as described before [21].
2.3. ATP hydrolysis-driven proton pumping and ATP synthase assays
ATP hydrolysis-driven proton pumping was measured using the
method described by Aggeler et al. [21] where changes in pH due to
proton pumping across the membrane are assayed with 9-amino-6-
chloro-2-methoxyacridine (ACMA) £uorescence quenching.
The ability of the mutants to synthesize ATP was measured as
follows: 150 mg of isolated inner membranes from each mutant was
resuspended in 5 ml 50 mM MOPS (pH 7.0), 20 mM MgCl2, 5 mM
K2PO4, 1 mM ADP. A 500 Wl aliquot was removed and 50 mM
NADH added to the remainder to start the synthesis of ATP. After
5 min incubation at 37‡C, the reaction was stopped with 1% TCA and
the samples incubated at room temperature for 10 min. After dilution
of the samples to less than 0.1% TCA concentration, the ATP content
was assayed using the bioluminescent ATP assay (BioOrbit).
3. Results
A list of mutations that have been reported to date in the
mitochondrially encoded ATPase subunit 6 gene is provided
in Table 2 along with the disease(s) caused. Also, the equiv-
alent mutations generated for the present study in the E. coli
enzyme are given. Table 2 lists ATPase activity measured
without and with LDAO present. With wild-type, the deter-
gent releases F1 from the constraints of the F0 part [22]. Three
other functional attributes of the ATP synthase were exam-
ined: DCCD sensitivity of the ATPase activity (Fig. 1), ATP-
driven proton pumping (Fig. 2), and ATP synthesis (Fig. 3).
The e¡ects of the mutations varied widely.
4. Discussion
Two mutants, L207P and V262P, were signi¢cantly im-
paired in ATP synthesis and had reduced sensitivity to
DCCD. In the case of the V262P mutation, there was a clear
e¡ect on proton pumping function as measured by the ACMA
quenching assay. The L207P mutant showed no major e¡ect
on proton pumping, although ATP synthesis was reduced by
50%, cf. 70% for V262P. This may re£ect the lack of sensi-
tivity of the ACMA quenching assay at optimal ATP hydrol-
Table 1
List of oligonucleotides used to create mutants
Human muta-
tion
E. coli mutation Oligonucleotide
8851 T-C 4457 TT-CG CAC TGG GCG TAC GTA TCC TGA
TTC
8993 T-C 4605 T-C CCA GTT TCA CCC GGT TTG CG
9101 T-C 4685 CA-AC GTG GTG GTC AAC GTG GAT CCT G
9176 T-C 4762 T-C CCT CAT GGT TCC GAC GAT CGT C
9185 T-C 4770 GT-CC CTG ATG ATC CCC TAT CTG TCG
Table 2
Mutations of ATPase 6 gene, equivalent mutations in the E. coli a subunit, and e¡ect on ATP hydrolysis
Human mutation Amino acid
change
Disease Reference Amino acid change
in E. coli
ATPase activity
basal
Level (fold) of stimulation of
ATPase activity by LDAO
T8851C W109R FSBN [8] F158R 1.1 3.3
T8993C L156P NARP/Leigh’s [9,10] L207P 1.1 4.3
T9101C I192T LHON [15] Q234T 0.7 5.9
T9176C L217P Leigh’s [11^13] L259P 0.7 5.3
T9185C L220P Leigh’s [14] V262P 1.2 2.9
Wild-type: 1.0 3.0
Fig. 1. DCCD sensitivity of ATP hydrolysis activity. Isolated inner
membranes from wild-type (black), F158R (diagonal stripes), L262P
(gray), and L207R (horizontal stripes) mutants were resuspended in
50 mM Tris-HCl, pH 7.5, 5 mM MgSO4 and 10% glycerol at a
concentration of 0.1 mg protein/ml. Samples were then incubated
with and without 40 WM and 60 WM DCCD for 1 h at 22‡C. ATP-
ase activities were measured as described by Lo«tscher et al. [22].
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ysis rates. The non-linearity of the ACMA quenching assay
has been described elsewhere [23].
The above data for V262P and L207P are consistent with
both mutations changing the structure of the a subunit, to
alter coupling between catalytic sites and the proton channel,
without fully destabilizing the binding of F1 to F0. In both
cases, this must be without disruption and opening of the
proton channel within the F0 because electron transfer linked
(NADH-driven) proton pumping was not altered measurably.
At levels close to homoplasmy, the T9185C mutation has been
reported to cause Leigh’s disease [14], while the T8993C mu-
tation has been reported to cause either NARP or Leigh’s
disease [9,10]. It is important to note that replacement of
Leu by Pro in the T8993C mutation is less deleterious than
the change of this Leu for Arg in the T8993G mutation. The
L207R mutation in E. coli results in a poorly assembled and
unstable enzyme [7,18]. At close to homoplasmy, the T8993G
causes severe Leigh’s disease [7^9].
Two other mutations, T9101C [15] (Q234T in E. coli) and
T9176C [11^13] (L259P in E. coli), a¡ected functioning of the
ATP synthase in a measurable way. In both, the membrane-
bound ATP hydrolysis activity was signi¢cantly lower than in
wild-type, but there was a high, essentially normal activated
ATPase activity in the presence of LDAO, giving a more than
¢vefold activation by the detergent compared to threefold in
wild-type or the V262P mutant. Neither the Q234T or L259P
mutations a¡ected proton pumping, DCCD sensitivity or
ATP synthesis rates. It appears, therefore, that these muta-
tions in the a subunit alter the extent to which the F0 part
controls the ATP hydrolysis reaction. This e¡ect is often ex-
plained as a reversal of the inhibiting e¡ect of the O subunit on
ATPase activity by binding of F1 to F0 [24,25]. Thus, the
ATPase activity of ECF1-O is 10-fold higher than that of
ECF1+O, but only threefold higher than that of ECF1F0. In
fact, the O subunit still exerts an e¡ect on ATPase rates in the
intact ATP synthase, as shown by both mutation studies of
the O subunit and proteolysis experiments [19,26,27]. Other
mutations in the a subunit that alter the e¡ect of the O subunit
on ATP hydrolysis have been reported recently [28].
How the T9101C and T9176C mutations cause LHON and
Leigh’s disease respectively is not made clear by the E. coli
studies. The same is true of the study of the 8851 T-C muta-
tion which converts a Trp at position 109 to an Arg in hu-
mans. In E. coli, the equivalent change of a Phe to Arg at
position 158 has an altered DCCD sensitivity, but no other
e¡ects on the functioning of the ATP synthase. It could be
that these last three described mutations are not the prime
cause of the observed phenotype. However, this is unlikely
Fig. 2. E¡ect of a subunit mutants on proton pumping. Isolated in-
ner membranes from the mutants and wild-type were resuspended
in 10 mM HEPES, pH 7.5, 100 mM KCl, 5 mM MgCl2 at a con-
centration of 0.1 mg protein/ml. To this resuspension, 3.6 WM vali-
nomycin was added as a K ionophore followed by 1 WM ACMA.
NADH (0.5 mM) was added, and the proton pumping by respira-
tory chain activity was thereby monitored. KCN (2 mM) was then
added to block respiration and ATP (2 mM) added to measure
ATP hydrolysis-driven proton translocation. Finally, nigericin at 3.6
WM was added to dissipate ion gradients. a: Wild-type (dashed line)
and L259P (solid line); b: wild-type (dashed line) and L207P (solid
line; c: wild-type (dashed line) and V262P (solid line).
Fig. 3. ATP synthesis by a subunit mutants. Inner membranes from
wild-type (black), L207P (horizontal stripes), Q234T (cross-hatches),
V262P (gray), L259P (vertical stripes) and F258R (diagonal stripes)
were treated as described in Section 2. ATP content was then as-
sayed using the BioOrbit bioluminescent ATP assay.
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as the polymorphism is rare and, in each case, there are ped-
igree studies to support the conclusion that these mutations
are pathogenic. One way that the T9101C, T9176C and
T8851C mutations could each a¡ect oxidative phosphoryla-
tion in humans is if these mutations alter the assembly and,
therefore, steady-state levels of the ATP synthase. The mam-
malian enzyme has several more subunits than the bacterial
ATP synthase [3,24,29], most of which are in the F0 and/or
stalk region. Altered interaction of the a subunit with these
additional subunits could cause instability or reduced assem-
bly of the complex. We have recently obtained monoclonal
antibodies against subunits of the human ATP synthase, and
can examine the assembly of the enzyme for the ¢rst time.
In summary, three known mutations of mtDNA in the
ATPase subunit 6 gene (two described here and one described
by Hartzog and Cain [18]) have now been shown to alter the
functioning of the ATP synthase to an extent expected to
a¡ect oxidative phosphorylation in human cells. In the
T8993C and T9176C mutants examined here, this is due to
alterations in the coupling between the F1 and the F0 part,
apparently in each case without making the membrane in-
creasingly permeable to protons. For both mutations in hu-
mans, the pathogenicity will depend on tissue distribution, the
extent of heteroplasmy, and the requirements for oxidative
phosphorylation, i.e. threshold for normal functioning of the
cell type.
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